Showing 9541-9550 of 21412 results for "".
Baylor's Pediatric AIDS Initiative
https://reachmd.com/programs/clinicians-roundtable/baylors-pediatric-aids-initiative/486/Dr. Mark Kline, Professor of Pediatrics and President of Baylor's Pediatrics AIDS Initiative talks about the program, its funding, what countries are part of the program and the work they've done to date.Negative Physician - Nurse Interactions
https://reachmd.com/programs/clinicians-roundtable/negative-physician-nurse-interactions/434/Kathleen Bartholomew RN, BS discusses the negative behavior that contributes to disruptive physician - nurse interactions.Diary of a Physician Working in Iraq
https://reachmd.com/programs/clinicians-roundtable/diary-of-a-physician-working-in-iraq/12/Dr. Jadick recalls the stress, the conditions and the daily challenges of a physician working under wartime conditions in Iraq.Hepatocellular Carcinoma: Examining Its Prevalence and Prognostic Biomarkers
https://reachmd.com/programs/project-oncology/hepatocellular-carcinoma-examining-its-prevalence-and-prognostic-biomarkers/24479/Join us as we explore the prevalence of hepatocellular carcinoma along with potential prognostic biomarkers that are currently being investigated.Urinary and Circulating Tumor DNA in Muscle-Invasive Bladder Cancer: NIAGARA Data
https://reachmd.com/programs/project-oncology/ctdna-muscle-invasive-bladder-cancer-niagara-data/36310/Could emerging biomarkers redefine how we assess response and recurrence risk in muscle-invasive bladder cancer? To find out, Dr. Charles Turck speaks with Dr. Petros Grivas about the key findings from the phase 3 NIAGARA trial. Together, they explore how perioperative durvalumab impacts circulatingThe Future of ITP Care: Exploring New Treatments
https://reachmd.com/programs/project-oncology/the-future-of-itp-care-exploring-new-treatments/26404/Learn about how new immune thrombocytopenia treatment options, including BTK inhibitors and immune therapies.Tapinarof’s Place in Inflammatory Disease Treatment
https://reachmd.com/programs/practical-dermatology/tapinarofs-place-in-inflammatory-disease-treatment/70706/In the second installment of this six-part series, Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, and Joshua Grosshandler, MD, FAAD, explain how tapinarof fits in the armamentarium for treating inflammatory dermatoses.Supplements and Cannabis in Breast Cancer Care: An Integrative Medicine Approach
https://reachmd.com/programs/project-oncology/supplements-and-cannabis-in-breast-cancer-care-an-integrative-medicine-approach/26409/Here’s how we can use an integrative medicine approach to balance evidence-based guidance on supplements and cannabis with patients’ goals.Diagnosing IgA Nephropathy: The Role of Immunofluorescence and Immunohistochemistry
https://reachmd.com/programs/frontlines-iga-nephropathy/diagnosing-iga-nephropathy-the-role-of-immunofluorescence-and-immunohistochemistry/26943/How is IgA nephropathy diagnosed and differentiated from similar diseases? Tune in to find out.The Future of IgA Nephropathy: Why Biomarkers Matter
https://reachmd.com/programs/frontlines-iga-nephropathy/the-future-of-iga-nephropathy-why-biomarkers-matter/26942/Dive into the importance of biomarkers in the intensifying pursuit of newer, more effective treatments for IgA nephropathy.